A herculean national effort has seen 69% of paused studies due to COVID restarted under the National Institute for Health Research’s (NIHR) Restart Framework. Experts from the institute tell us how those numbers can be further boosted, and how lessons learned from the sector-wide collaboration… Read More »Inside the UK’s leading efforts to restart clinical research
Pfizer may have been making headlines with the COVID vaccine it developed with BioNTech, but it’s not the only infectious disease the big pharma is targeting. In a statement, Pfizer said the FDA has granted a fast review for TicoVac tick-borne encephalitis (TBE) vaccine, to… Read More »Pfizer files tick-borne encephalitis shot with FDA
COVID-19 vaccine hesitancy remains an ongoing challenge to our nation’s public health efforts. According to a just-published KFF survey, 31% of Americans report they will take a “wait and see” approach to vaccination, 7% say they will accept a vaccine only if required, and 13%… Read More »How to Create an Effective COVID-19 Vaccine Communication Strategy for Your Patients
Horizon Therapeutics Bolsters its Rare Disease Portfolio in a $3B Viela Bio Buyout Horizon Therapeutics has announced to acquire Viela Bio for about $3.1 billion to augment its portfolio and pipeline of treatments for rare diseases. The shares of Viela Bio skyrocketed more than 52%… Read More »Horizon, Viela Deal; Concert Schizo Drug Flop; Gilead Deals with Arcus and Gritstone
The healthcare system is running at its limits in many countries worldwide. One reason is the growing demand for healthcare, largely driven by the rise of chronic diseases. COVID-19 has further underscored just how stretched the system is today. Is there any solution to the… Read More »Digital therapeutics: Why human psychology is key to adoption
Tomorrow, Monday, November 16 at 15:00 CET (9:00 EST/6:00 PST), I will be on an ISPOR Europe Panel titled “Will COVID-19 Accelerate the Adoption of Digital Health Technologies? Perspectives on Evaluating Digital Health Technologies during Global Disease Outbreaks“. The session will be moderated by Kristian… Read More »ISPOR Europe Panel: “Will COVID-19 Accelerate the Adoption of Digital Health Technologies?”
COVID19: The Impact of the Early Failure to Respond The well-documented COVID19 chapter of Abramson’s book, Proof of Conspiracy, details our early failure to respond. Here’s why it matters. The Doctor Weighs In
The post 2 billion vials. Public acceptance. The obstacles to vaccine delivery appeared first on Healthy Debate.
Dealing with a Rare Eye Disease in the Midst of COVID19 After being diagnosed with a rare eye disease, a doctor learns the best treatment is immunosuppression-a risky choice in the midst of COVID19 The Doctor Weighs In
Novartis’s Spartalizumab Combo Stubles; Union Therapeutics Doses In COVID-19 Trial; Yumanity To Merge With Proteostasis
Novartis’s Spartalizumab Combo Fails To Meet The Primary Goal In The Melanoma Trial Novartis recently declared the results of its Phase III COMBI-I trial evaluating its experimental checkpoint inhibitor spartalizumab in combination with Tafinlar (dabrafenib) and Mekinist (trametinib) for patients, previously untreated, with unresectable or… Read More »Novartis’s Spartalizumab Combo Stubles; Union Therapeutics Doses In COVID-19 Trial; Yumanity To Merge With Proteostasis
Dr. Jim Merlino, Chief Clinical Transformation Officer, Cleveland Clinic Despite having entered the US eight months ago, COVID-19 remains a topic enshrouded in confusion, conflicting information, hyperbole, and even conspiracy theories. Everyone, informed or not, seems to have an opinion about the coronavirus pandemic. Fortunately,… Read More »[Podcast] How Cleveland Clinic Helps Employers Create a Safer Workplace During COVID-19
School leaders in Elk Grove, California, wanted to leave as little to chance as possible. So they brought nearly 150 voices into their decision-making process, and canvassed the parents of the estimated 63,000 students in the district to ask how they wanted their children taught.… Read More »California School Districts Grope for Sensible Reopening Plans
Congressional leaders are squaring off over the next pandemic relief bill in a debate over whom Congress should step up to protect: front-line workers seeking more safeguards from the ravages of COVID-19 or beleaguered employers seeking relief from lawsuits. Democrats want to enact an emergency… Read More »Next Showdown in Congress: Protecting Workers vs. Protecting Employers in the Pandemic
Dana Callow, Executive Creative Director, Healthcare Success COVID-19 has been a life-changing event for us all. It’s the kind of event that has lasting effects on people that we can’t even truly see just yet. We’ve thrust an entire population into a cycle of grief… Read More »[Podcast] How to Adjust Your Creative Strategies In Response to the COVID-19 Pandemic?
COVID-19: The New Normal for Healthcare Consumers A “new normal” is emerging in healthcare for both providers and patients. Healthcare industry leaders and medical marketing professionals constantly struggle to keep pace with changes. We all have the challenge of adjusting to pandemic demands and shifting… Read More »How Are Healthcare Consumers Responding to the Coronavirus Pandemic?
In a world jam-packed with COVID-19 information and communications, home health centers are looking for direction. Not only are they adapting to PDGM—the most significant change to Medicare’s payment methodology for home health services in nearly 20 years—but they are also facing strong headwinds from… Read More »Key learnings for the intersection between PDGM and COVID-19 (webinar)
Gloves form an essential part of the personal protective equipment (PPE). However, unlike masks, gloves are not supposed to be worn all the time or when outdoors to buy groceries. As per the U.S. Centers for Disease Control and Prevention (CDC), gloves should be worn… Read More »When to Wear Gloves To Prevent COVID-19?
A conversation between Navin Gupta, Vice President, Home Care Solutions for MatrixCare and his special guest Jeremy Crow, Senior Software Executive, Information Technology Consultant, and Certified Project Manager for HEALTHCAREfirst about RCM support through COVID-19, PDGM, and beyond.
The post Low-income Ontarians facing partial claw back of federal assistance during COVID-19 appeared first on Healthy Debate.
Marketing Strategies to Implement Now For Your Vein Practice A Webinar Sponsored by the American Vein and Lymphatic Society COVID-19 has caused massive economic disruption to virtually every kind of business, including vein practices. Which marketing strategies should you begin now, and which should you… Read More »Vein Practice Marketing Strategies to Implement Now
March 17, 2020, may well be remembered as the day the telemedicine revolution finally took off. Telemedicine and Telehealth‘s adoption, fast-tracked by Coronavirus/COVID, will create profound changes in how healthcare services are provided — while also spawning new healthcare marketing opportunities. Telemedicine & Telehealth: Innovation &… Read More »
COVID Healthcare Marketing Webinar COVID-19 has changed the healthcare industry quicker in the last two weeks than in the last 50 years. With medical practices temporarily shutting down and elective procedures put on hold, what should healthcare networks and healthcare specialists do with their marketing… Read More »COVID Healthcare Marketing Questions: Pause, Pivot, or Push Forward